Previous 10 | Next 10 |
home / stock / lzagy / lzagy news
iSpecimen has filed to raise $20 million in an IPO. The firm operates a human biospecimen online marketplace. ISPN has grown from a small revenue base and operates in a promising industry, so I look forward to learning about the IPO's pricing and valuation assumptions. For f...
The contingent value right issued to Celgene shareholders after the Bristol-Myers acquisitions are dependent on approval of Liso-cell and Ide-cell. For Liso-cell to be approved the FDA seems insistent on inspection of a Texas-based Lonza facility. Twitter sources point toward a ph...
Under its new supply agreement with the United Kingdom's government, Moderna (MRNA) will supply a total of 7M mRNA-1273 doses to the U.K., beginning in March.The company said it's continuing to scale up its global manufacturing to be able to deliver ~500M doses per year and possibly...
Moderna's (MRNA) vaccine candidate against COVID-19, mRNA-1273, is now eligible for submission of an application for a European Union Marketing Authorization under the European Medicine Agency's centralized procedure.The submission follows positive results from a preclinical viral challenge s...
BASEL, Switzerland and BRANFORD, Conn. , Aug. 20, 2020 /PRNewswire/ -- Quote from Matthew Hewitt , Head of Clinical Development and Personalized Medicine, Lonza: "This collaboration between Lonza and IsoPlexis highlights the evolution of cell therapy manufacturing. As we continue...
The Problem You are not going to find a standard valuation metric to validate the stock price of any of the leading COVID-19 vaccines that are currently in clinical trials. To the contrary, the measure is market potential if, perchance, one or more of these companies gain regulatory approval...
Original post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...
New York City, NY: May 25, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Low Dielectric Resin Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and info...
New York City, NY: May 25, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Cosmetic Raw Materials Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and in...
New York City, NY: May 25, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Metal Forming Fluids Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and info...
News, Short Squeeze, Breakout and More Instantly...
Lonza Group AG ADR Company Name:
LZAGY Stock Symbol:
OTCMKTS Market:
NeuroSense Announces First Quarter 2024 Business Update PR Newswire CAMBRIDGE, Mass. , May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today ...
FFW Corp. (FFWC) is expected to report for Q2 2024 ResMed Inc. (RMD) is expected to report $1.81 for Q2 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2023-12-31 ChoiceOne Financial Services Inc. (COFS) is expected to report $0.64 for Q4 2023 First ...
Lonza Group AG ADR (LZAGY) is expected to report for Q4 2023